Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting

Core Points - Coloplast's interim CEO Lars Rasmussen will not stand for re-election at the upcoming Annual General Meeting on December 4, 2025 [1] - Lars Rasmussen has served Coloplast for nearly four decades, including 10 years as CEO and 7 years as Chair of the Board, significantly contributing to its transformation into a leading global MedTech company [2][5] - The company is entering a new phase with the implementation of its Impact4 strategy, which aims to help 4 million people with intimate healthcare needs [4][7] Company Leadership Changes - Jette Nygaard-Andersen will continue as interim Chair of the Board, leading the company during this transitional period [5] - Niels B. Christiansen is proposed as a new Board member, expected to become Chair by December 2026, bringing relevant experience from the hearing aids industry and a strong customer-focused leadership background [6][7] - The Board of Directors supports the leadership changes and the search for a new CEO is progressing as planned [8]